ETX.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:45):

e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing...

Stats
Today's Volume	475 706
Average Volume	575 537
Market Cap	58.58M
EPS	£0 ( 2023-10-25 )
Next earnings date	( £0 ) 2024-05-01
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-5.01
ATR14	£0.333 (3.32%)

E-Therapeutics PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

E-Therapeutics PLC Financials

Annual	2022
Revenue:	£475 000
Gross Profit:	£475 000 (100.00 %)
EPS:	£-0.0154

Q2	2023
Revenue:	£160 000
Gross Profit:	£-111 000 (-69.38 %)
EPS:	£-0.00960

Q4	2022
Revenue:	£180 000
Gross Profit:	£180 000 (100.00 %)
EPS:	£-0.00800

Q3	2022
Revenue:	£90 000.00
Gross Profit:	£90 000.00 (100.00 %)
EPS:	£-0.00400

Financial Reports:

No articles found.

E-Therapeutics PLC